MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/archdischild-2016-312185

Медицинская библиотека · Archives of disease in childhood · 2017

Late outcomes in children with Langerhans cell histiocytosis.

Chow Tin Wai, Leung Wing Kwan, Cheng Frankie Wai Tsoi, Kumta Shekhar Medhukar, Chu Winnie Chiu Wing, Lee Vincent, Shing Matthew Ming Kong, Li Chi Kong

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Langerhans cell histiocytosis (LCH) is a rare disease with diverse clinical courses. Despite improvement in survival outcomes in the recent decades, sequelae of the disease remain a concern. This study aimed to provide information on the long-term outcomes in patients with LCH, particularly on the sequelae and any associated factors.

METHOD: Medical records of patients with diagnosis of LCH and being managed in our centre were retrospectively reviewed. Data on the courses of illness, mortality, intervention, types and time of late events were collected and analysed.

RESULTS

70 patients were included with a mean observation time of 12 years (median 10.7 years, range 1-31.3 years). Sequelae related to LCH were present in 56% (n=39), being more common in multisystem diseases and patients with reactivations. Prevalence of sequelae is as follows: orthopaedic related 27%, diabetes insipidus 19%, growth retardation 13%, cosmetic 10%, neurological 7%, hearing 7%, anterior pituitary hormone deficiency 7%, hepatobiliary 4% and ophthalmological 3%. Neurological sequelae could manifest even 10 years after initial diagnosis of LCH. Reactivations, presence of central nervous system (CNS) risk lesions and treatment with radiotherapy were associated with a higher rate of sequelae. The cumulative incidence of reactivation was 34%. Most reactivations occurred in the first 2.5 years after diagnosis.

CONCLUSION

Sequelae were common after LCH, although some were mild. Neurological sequelae could be particularly severe and debilitating. Vigilant long-term follow-up would be essential for optimising patient outcomes. Further studies on the prevention and treatment of CNS disease of LCH are warranted.

Для цитирования: Chow Tin Wai, Leung Wing Kwan, Cheng Frankie Wai Tsoi, Kumta Shekhar Medhukar, Chu Winnie Chiu Wing, Lee Vincent, Shing Matthew Ming Kong, Li Chi Kong. Late outcomes in children with Langerhans cell histiocytosis.. Archives of disease in childhood. 2017. DOI: 10.1136/archdischild-2016-312185.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.